glp-1 news today october 23 2025 Consumers' Expectations about Drugs Economic Impact on Food System Players Who Gets the Shot? GLP-1
Description
However, doses of 120mg twice daily were shown to be more associated with the production of reduced appetite, dyspepsia and dizziness
2011;6:e25221
Legal claims assert that GlaxoSmithKline, the manufacturer of Alli, did not properly warn users about the potential for liver toxicity, especially among individuals with preexisting conditions or those who were using the drug for extended periods
If side effects become severe or do not go away, speak to your doctor
Frequently Asked Questions Why are there two different protocols for the same drug
